The serum HDL separation was performed by size-exclusion chromatography (SEC) using a previously described method [67 (
link)]. Briefly, fractions were determined in 50 μL of serum samples diluted with 50 μL of a PBS solution via SEC, using a
Superose 6 increase column (10/300GL, 10 × 300, 24 mL), (GE Healthcare; Uppsala, Sweden). SEC was carried out using an
ÄKTA purifier 10 (GE Healthcare; Uppsala, Sweden), equipped with a fraction collector (
Frac-950). The system was controlled by a UNICORN control system, version 4.10 (GE Healthcare; Uppsala, Sweden). The SEC flow rate was set at 450 μL/min. Eluting fractions were collected in glass-coated 96-well plates (Eppendorf Protein Low-Bind; Hamburg, Germany). The HDL fractions were combined after fractionation, and samples were dried in a vacuum centrifuge and stored at −80 °C before further processing. Lipids from the selected fractions obtained by Superose-6 SEC were further extracted and investigated by LC-MS, as detailed below.
Mocciaro G., D’Amore S., Jenkins B., Kay R., Murgia A., Herrera-Marcos L.V., Neun S., Sowton A.P., Hall Z., Palma-Duran S.A., Palasciano G., Reimann F., Murray A., Suppressa P., Sabbà C., Moschetta A., Koulman A., Griffin J.L, & Vacca M. (2022). Lipidomic Approaches to Study HDL Metabolism in Patients with Central Obesity Diagnosed with Metabolic Syndrome. International Journal of Molecular Sciences, 23(12), 6786.